Click for best price
Cancer Genome Sequencing Market Size, Share 2023
Cancer genome sequencing refers to a method used to identify the complete DNA or RNA sequence of cancer cells based on the sequencing of a single, homogeneous or heterogeneous group of tumor cells.
This report aims to provide a comprehensive presentation of the global market for Cancer Genome Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Genome Sequencing. This report contains market size and forecasts of Cancer Genome Sequencing in global, including the following market information:
Global Cancer Genome Sequencing Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Genome Sequencing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
It is a laboratory technique that characterizes DNA or RNA sequences of primary tumor tissue, the tumor micro environment (such as stromal / fibroblast cells), adjacent or distal normal tissue, or metastatic tumor sites. This technique generates information related to identification of nucleotide bases (DNA or RNA), mutation status, copy number and sequence variants, as well as structural variations including fusion genes and chromosomal translocations.
We surveyed the Cancer Genome Sequencing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Genome Sequencing Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cancer Genome Sequencing Market Segment Percentages, by Type, 2022 (%)
Second Generation
Third Generation
Global Cancer Genome Sequencing Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cancer Genome Sequencing Market Segment Percentages, by Application, 2022 (%)
Treatment
Research
Global Cancer Genome Sequencing Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cancer Genome Sequencing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Genome Sequencing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Genome Sequencing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Agilent Technologies
GE Healthcare Life Sciences
Johnson & Johnson
LI-COR Biosciences
Abbott Laboratories
Beckman Coulter
Bayer
Hamilton Thorne Biosciences
Integrated DNA Technologies
Microchip Biotechnologies
Myriad Genetics
Commonwealth Biotechnologies
ZS Genetics
Pacific Biosciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Genome Sequencing, market overview.
Chapter 2: Global Cancer Genome Sequencing market size in revenue.
Chapter 3: Detailed analysis of Cancer Genome Sequencing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Genome Sequencing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cancer Genome Sequencing Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Genome Sequencing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Genome Sequencing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Genome Sequencing Overall Market Size
2.1 Global Cancer Genome Sequencing Market Size: 2022 VS 2029
2.2 Global Cancer Genome Sequencing Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Genome Sequencing Players in Global Market
3.2 Top Global Cancer Genome Sequencing Companies Ranked by Revenue
3.3 Global Cancer Genome Sequencing Revenue by Companies
3.4 Top 3 and Top 5 Cancer Genome Sequencing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Genome Sequencing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Genome Sequencing Players in Global Market
3.6.1 List of Global Tier 1 Cancer Genome Sequencing Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Genome Sequencing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Genome Sequencing Market Size Markets, 2022 & 2029
4.1.2 Second Generation
4.1.3 Third Generation
4.2 By Type - Global Cancer Genome Sequencing Revenue & Forecasts
4.2.1 By Type - Global Cancer Genome Sequencing Revenue, 2018-2023
4.2.2 By Type - Global Cancer Genome Sequencing Revenue, 2024-2029
4.2.3 By Type - Global Cancer Genome Sequencing Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Genome Sequencing Market Size, 2022 & 2029
5.1.2 Treatment
5.1.3 Research
5.2 By Application - Global Cancer Genome Sequencing Revenue & Forecasts
5.2.1 By Application - Global Cancer Genome Sequencing Revenue, 2018-2023
5.2.2 By Application - Global Cancer Genome Sequencing Revenue, 2024-2029
5.2.3 By Application - Global Cancer Genome Sequencing Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cancer Genome Sequencing Market Size, 2022 & 2029
6.2 By Region - Global Cancer Genome Sequencing Revenue & Forecasts
6.2.1 By Region - Global Cancer Genome Sequencing Revenue, 2018-2023
6.2.2 By Region - Global Cancer Genome Sequencing Revenue, 2024-2029
6.2.3 By Region - Global Cancer Genome Sequencing Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cancer Genome Sequencing Revenue, 2018-2029
6.3.2 US Cancer Genome Sequencing Market Size, 2018-2029
6.3.3 Canada Cancer Genome Sequencing Market Size, 2018-2029
6.3.4 Mexico Cancer Genome Sequencing Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cancer Genome Sequencing Revenue, 2018-2029
6.4.2 Germany Cancer Genome Sequencing Market Size, 2018-2029
6.4.3 France Cancer Genome Sequencing Market Size, 2018-2029
6.4.4 U.K. Cancer Genome Sequencing Market Size, 2018-2029
6.4.5 Italy Cancer Genome Sequencing Market Size, 2018-2029
6.4.6 Russia Cancer Genome Sequencing Market Size, 2018-2029
6.4.7 Nordic Countries Cancer Genome Sequencing Market Size, 2018-2029
6.4.8 Benelux Cancer Genome Sequencing Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cancer Genome Sequencing Revenue, 2018-2029
6.5.2 China Cancer Genome Sequencing Market Size, 2018-2029
6.5.3 Japan Cancer Genome Sequencing Market Size, 2018-2029
6.5.4 South Korea Cancer Genome Sequencing Market Size, 2018-2029
6.5.5 Southeast Asia Cancer Genome Sequencing Market Size, 2018-2029
6.5.6 India Cancer Genome Sequencing Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cancer Genome Sequencing Revenue, 2018-2029
6.6.2 Brazil Cancer Genome Sequencing Market Size, 2018-2029
6.6.3 Argentina Cancer Genome Sequencing Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Genome Sequencing Revenue, 2018-2029
6.7.2 Turkey Cancer Genome Sequencing Market Size, 2018-2029
6.7.3 Israel Cancer Genome Sequencing Market Size, 2018-2029
6.7.4 Saudi Arabia Cancer Genome Sequencing Market Size, 2018-2029
6.7.5 UAE Cancer Genome Sequencing Market Size, 2018-2029
7 Cancer Genome Sequencing Companies Profiles
7.1 Agilent Technologies
7.1.1 Agilent Technologies Company Summary
7.1.2 Agilent Technologies Business Overview
7.1.3 Agilent Technologies Cancer Genome Sequencing Major Product Offerings
7.1.4 Agilent Technologies Cancer Genome Sequencing Revenue in Global Market (2018-2023)
7.1.5 Agilent Technologies Key News & Latest Developments
7.2 GE Healthcare Life Sciences
7.2.1 GE Healthcare Life Sciences Company Summary
7.2.2 GE Healthcare Life Sciences Business Overview
7.2.3 GE Healthcare Life Sciences Cancer Genome Sequencing Major Product Offerings
7.2.4 GE Healthcare Life Sciences Cancer Genome Sequencing Revenue in Global Market (2018-2023)
7.2.5 GE Healthcare Life Sciences Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Cancer Genome Sequencing Major Product Offerings
7.3.4 Johnson & Johnson Cancer Genome Sequencing Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 LI-COR Biosciences
7.4.1 LI-COR Biosciences Company Summary
7.4.2 LI-COR Biosciences Business Overview
7.4.3 LI-COR Biosciences Cancer Genome Sequencing Major Product Offerings
7.4.4 LI-COR Biosciences Cancer Genome Sequencing Revenue in Global Market (2018-2023)
7.4.5 LI-COR Biosciences Key News & Latest Developments
7.5 Abbott Laboratories
7.5.1 Abbott Laboratories Company Summary
7.5.2 Abbott Laboratories Business Overview
7.5.3 Abbott Laboratories Cancer Genome Sequencing Major Product Offerings
7.5.4 Abbott Laboratories Cancer Genome Sequencing Revenue in Global Market (2018-2023)
7.5.5 Abbott Laboratories Key News & Latest Developments
7.6 Beckman Coulter
7.6.1 Beckman Coulter Company Summary
7.6.2 Beckman Coulter Business Overview
7.6.3 Beckman Coulter Cancer Genome Sequencing Major Product Offerings
7.6.4 Beckman Coulter Cancer Genome Sequencing Revenue in Global Market (2018-2023)
7.6.5 Beckman Coulter Key News & Latest Developments
7.7 Bayer
7.7.1 Bayer Company Summary
7.7.2 Bayer Business Overview
7.7.3 Bayer Cancer Genome Sequencing Major Product Offerings
7.7.4 Bayer Cancer Genome Sequencing Revenue in Global Market (2018-2023)
7.7.5 Bayer Key News & Latest Developments
7.8 Hamilton Thorne Biosciences
7.8.1 Hamilton Thorne Biosciences Company Summary
7.8.2 Hamilton Thorne Biosciences Business Overview
7.8.3 Hamilton Thorne Biosciences Cancer Genome Sequencing Major Product Offerings
7.8.4 Hamilton Thorne Biosciences Cancer Genome Sequencing Revenue in Global Market (2018-2023)
7.8.5 Hamilton Thorne Biosciences Key News & Latest Developments
7.9 Integrated DNA Technologies
7.9.1 Integrated DNA Technologies Company Summary
7.9.2 Integrated DNA Technologies Business Overview
7.9.3 Integrated DNA Technologies Cancer Genome Sequencing Major Product Offerings
7.9.4 Integrated DNA Technologies Cancer Genome Sequencing Revenue in Global Market (2018-2023)
7.9.5 Integrated DNA Technologies Key News & Latest Developments
7.10 Microchip Biotechnologies
7.10.1 Microchip Biotechnologies Company Summary
7.10.2 Microchip Biotechnologies Business Overview
7.10.3 Microchip Biotechnologies Cancer Genome Sequencing Major Product Offerings
7.10.4 Microchip Biotechnologies Cancer Genome Sequencing Revenue in Global Market (2018-2023)
7.10.5 Microchip Biotechnologies Key News & Latest Developments
7.11 Myriad Genetics
7.11.1 Myriad Genetics Company Summary
7.11.2 Myriad Genetics Business Overview
7.11.3 Myriad Genetics Cancer Genome Sequencing Major Product Offerings
7.11.4 Myriad Genetics Cancer Genome Sequencing Revenue in Global Market (2018-2023)
7.11.5 Myriad Genetics Key News & Latest Developments
7.12 Commonwealth Biotechnologies
7.12.1 Commonwealth Biotechnologies Company Summary
7.12.2 Commonwealth Biotechnologies Business Overview
7.12.3 Commonwealth Biotechnologies Cancer Genome Sequencing Major Product Offerings
7.12.4 Commonwealth Biotechnologies Cancer Genome Sequencing Revenue in Global Market (2018-2023)
7.12.5 Commonwealth Biotechnologies Key News & Latest Developments
7.13 ZS Genetics
7.13.1 ZS Genetics Company Summary
7.13.2 ZS Genetics Business Overview
7.13.3 ZS Genetics Cancer Genome Sequencing Major Product Offerings
7.13.4 ZS Genetics Cancer Genome Sequencing Revenue in Global Market (2018-2023)
7.13.5 ZS Genetics Key News & Latest Developments
7.14 Pacific Biosciences
7.14.1 Pacific Biosciences Company Summary
7.14.2 Pacific Biosciences Business Overview
7.14.3 Pacific Biosciences Cancer Genome Sequencing Major Product Offerings
7.14.4 Pacific Biosciences Cancer Genome Sequencing Revenue in Global Market (2018-2023)
7.14.5 Pacific Biosciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Genome Sequencing Market Opportunities & Trends in Global Market
Table 2. Cancer Genome Sequencing Market Drivers in Global Market
Table 3. Cancer Genome Sequencing Market Restraints in Global Market
Table 4. Key Players of Cancer Genome Sequencing in Global Market
Table 5. Top Cancer Genome Sequencing Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Genome Sequencing Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Genome Sequencing Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Genome Sequencing Product Type
Table 9. List of Global Tier 1 Cancer Genome Sequencing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Genome Sequencing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Genome Sequencing Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cancer Genome Sequencing Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Genome Sequencing Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Cancer Genome Sequencing Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cancer Genome Sequencing Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Genome Sequencing Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Cancer Genome Sequencing Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cancer Genome Sequencing Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Genome Sequencing Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Genome Sequencing Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Genome Sequencing Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Genome Sequencing Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Genome Sequencing Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Genome Sequencing Revenue, (US$, Mn), 2024-2029
Table 30. Agilent Technologies Company Summary
Table 31. Agilent Technologies Cancer Genome Sequencing Product Offerings
Table 32. Agilent Technologies Cancer Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 33. Agilent Technologies Key News & Latest Developments
Table 34. GE Healthcare Life Sciences Company Summary
Table 35. GE Healthcare Life Sciences Cancer Genome Sequencing Product Offerings
Table 36. GE Healthcare Life Sciences Cancer Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 37. GE Healthcare Life Sciences Key News & Latest Developments
Table 38. Johnson & Johnson Company Summary
Table 39. Johnson & Johnson Cancer Genome Sequencing Product Offerings
Table 40. Johnson & Johnson Cancer Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 41. Johnson & Johnson Key News & Latest Developments
Table 42. LI-COR Biosciences Company Summary
Table 43. LI-COR Biosciences Cancer Genome Sequencing Product Offerings
Table 44. LI-COR Biosciences Cancer Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 45. LI-COR Biosciences Key News & Latest Developments
Table 46. Abbott Laboratories Company Summary
Table 47. Abbott Laboratories Cancer Genome Sequencing Product Offerings
Table 48. Abbott Laboratories Cancer Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 49. Abbott Laboratories Key News & Latest Developments
Table 50. Beckman Coulter Company Summary
Table 51. Beckman Coulter Cancer Genome Sequencing Product Offerings
Table 52. Beckman Coulter Cancer Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 53. Beckman Coulter Key News & Latest Developments
Table 54. Bayer Company Summary
Table 55. Bayer Cancer Genome Sequencing Product Offerings
Table 56. Bayer Cancer Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 57. Bayer Key News & Latest Developments
Table 58. Hamilton Thorne Biosciences Company Summary
Table 59. Hamilton Thorne Biosciences Cancer Genome Sequencing Product Offerings
Table 60. Hamilton Thorne Biosciences Cancer Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 61. Hamilton Thorne Biosciences Key News & Latest Developments
Table 62. Integrated DNA Technologies Company Summary
Table 63. Integrated DNA Technologies Cancer Genome Sequencing Product Offerings
Table 64. Integrated DNA Technologies Cancer Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 65. Integrated DNA Technologies Key News & Latest Developments
Table 66. Microchip Biotechnologies Company Summary
Table 67. Microchip Biotechnologies Cancer Genome Sequencing Product Offerings
Table 68. Microchip Biotechnologies Cancer Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 69. Microchip Biotechnologies Key News & Latest Developments
Table 70. Myriad Genetics Company Summary
Table 71. Myriad Genetics Cancer Genome Sequencing Product Offerings
Table 72. Myriad Genetics Cancer Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 73. Myriad Genetics Key News & Latest Developments
Table 74. Commonwealth Biotechnologies Company Summary
Table 75. Commonwealth Biotechnologies Cancer Genome Sequencing Product Offerings
Table 76. Commonwealth Biotechnologies Cancer Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 77. Commonwealth Biotechnologies Key News & Latest Developments
Table 78. ZS Genetics Company Summary
Table 79. ZS Genetics Cancer Genome Sequencing Product Offerings
Table 80. ZS Genetics Cancer Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 81. ZS Genetics Key News & Latest Developments
Table 82. Pacific Biosciences Company Summary
Table 83. Pacific Biosciences Cancer Genome Sequencing Product Offerings
Table 84. Pacific Biosciences Cancer Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 85. Pacific Biosciences Key News & Latest Developments
List of Figures
Figure 1. Cancer Genome Sequencing Segment by Type in 2022
Figure 2. Cancer Genome Sequencing Segment by Application in 2022
Figure 3. Global Cancer Genome Sequencing Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Genome Sequencing Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cancer Genome Sequencing Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Genome Sequencing Revenue in 2022
Figure 8. By Type - Global Cancer Genome Sequencing Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cancer Genome Sequencing Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cancer Genome Sequencing Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cancer Genome Sequencing Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cancer Genome Sequencing Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cancer Genome Sequencing Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cancer Genome Sequencing Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cancer Genome Sequencing Revenue Market Share, 2018-2029
Figure 16. US Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cancer Genome Sequencing Revenue Market Share, 2018-2029
Figure 20. Germany Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 21. France Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cancer Genome Sequencing Revenue Market Share, 2018-2029
Figure 28. China Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 32. India Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cancer Genome Sequencing Revenue Market Share, 2018-2029
Figure 34. Brazil Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cancer Genome Sequencing Revenue Market Share, 2018-2029
Figure 37. Turkey Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cancer Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 41. Agilent Technologies Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. GE Healthcare Life Sciences Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Johnson & Johnson Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. LI-COR Biosciences Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Abbott Laboratories Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Beckman Coulter Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Bayer Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Hamilton Thorne Biosciences Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Integrated DNA Technologies Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Microchip Biotechnologies Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Myriad Genetics Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Commonwealth Biotechnologies Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. ZS Genetics Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Pacific Biosciences Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
